May 21, 2024


Savvy business masters

FDA warns companies selling products that claim to treat coronavirus disease

SILVER SPRING, Maryland: The US Food & Drug Administration (FDA) and the Federal Trade Commission (FTC) on Monday (Mar 9) issued warning letters to seven companies for selling products that claim to prevent, treat or cure COVID-19 caused by the new coronavirus.

The health agency said such products may cause consumers to delay or stop from reaching out for appropriate medical care, leading to serious and life-threatening harm.

“There already is a high level of anxiety over the potential spread of coronavirus,” said FTC Chairman Joe Simons.

“What we don’t need in this situation are companies preying on consumers by promoting products with fraudulent prevention and treatment claims.

READ: US coronavirus cases pass 500 as defiant Trump praises response

The FDA and FTC jointly issued warning letters to Vital Silver, Quinessence Aromatherapy Ltd, Xephyr LLC doing business as N-Ergetics, GuruNanda LLC, Vivify Holistic Clinic, Herbal Amy LLC, and The Jim Bakker Show.

The products cited in these letters are teas, essential oils, tinctures and colloidal silver. The FDA had previously warned that colloidal silver is not safe or effective for treating any disease or condition.

None of the companies immediately responded to Reuters’ request for comment.

There are currently no vaccines or drugs approved to treat or prevent COVID-19, only investigational COVID-19 vaccines and treatments under development.

READ: Scientists race to develop vaccine for new coronavirus

The flu-like disease has infected more than 110,000 people in 105 countries and territories and 3,800 have died, the vast majority in mainland China, according to a Reuters tally.

READ: China reports zero locally transmitted COVID-19 cases outside Hubei

BOOKMARK THIS: Our comprehensive coverage of the novel coronavirus and its development

Download our app or subscribe to our Telegram channel for the latest updates on the coronavirus outbreak:

Source Article